Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211) Clinical trials frequently include multiple end points ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results